Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06463054 · ClinicalTrials.gov registry record · NA

Testing an Intergenerational Model of Suicide Risk in Mother-child Dyads

A NA study of Emotion Regulation, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06463054: Recruiting NA study of Emotion Regulation, sponsored by University of Pittsburgh.

NCT06463054 is a NA study of Emotion Regulation that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 150 participants, below the 195-participant average among 25 other Emotion Regulation trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06463054, a NA study of Emotion Regulation, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The investigators are interested in learning more about how the role of mothers' emotions has on the transmission of suicide risk to children. Eligible participants will be invited to participate in a baseline assessment, and 4 follow-up assessments in the next year. This research study is a randomized control trial. Participants that choose to enroll are randomly assigned, that is by chance (like by flipping a coin) to receive DBT Skills Training or treatment as usual (TAU). Participants may also be selected for DBT skills training, it which would occur once a week for 6 months.

Primary Outcome

Suicidal thoughts and behaviors will be assessed by the Columbia Suicide Severity Rating Scale (C-SSRS). C-SSRS will be scored with these domains, higher scores indicate worse outcomes Suicidal Ideation (Highest Level Endorsed 1-5) Intensity of Ideation (2-25) Suicidal Behavior (present during time period) Y/N Medical Damage for Attempt (0-5) Potential Lethality (if medical damage = 0) (0-2)

Conditions Studied

Interventions

  • BEHAVIORAL Dialectical Behavior Therapy Skills Group Training
  • BEHAVIORAL Safety Planning Intervention

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-04-01
Est. Completion 2028-03-31
Phase NA
University of Pittsburgh

1,238 total trials

What NCT06463054 shows while recruiting

NCT06463054 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 195-participant average among 25 other Emotion Regulation trials with a reported enrollment target (23% lower).

The record links to 1 condition, with Emotion Regulation appearing as the primary indexed condition, and to 2 interventions - of which Dialectical Behavior Therapy Skills Group Training is the first listed.

NCT06463054 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06463054 about?

NCT06463054 is a clinical study titled "Testing an Intergenerational Model of Suicide Risk in Mother-child Dyads". The investigators are interested in learning more about how the role of mothers' emotions has on the transmission of suicide risk to children. Eligible participants will be invited to participate in a baseline assessment, and 4 follow-up assessments in the next year. This research study is a randomi...

What is the current status of trial NCT06463054?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-04-01. Estimated completion is 2028-03-31.

What conditions does trial NCT06463054 study?

This clinical trial studies the following conditions: Emotion Regulation.

What interventions are being tested in trial NCT06463054?

The interventions under investigation include: Dialectical Behavior Therapy Skills Group Training (BEHAVIORAL), Safety Planning Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06463054?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06463054 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Emotion Regulation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06463054's enrollment target sits among peer trials

150 13th of 25 higher than 13 of 25 other Emotion Regulation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Emotion Regulation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06463054, the US trial registry maintained by the National Library of Medicine. NCT06463054 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.